Published in Cancer Weekly, January 4th, 2005
These results were reported at the 46th Annual Meeting of the American Society of Hematology (ASH).
A multi-center phase 2 study sponsored by the National Cancer Institute and led by Owen A. O'Connor, MD, PhD, of Memorial Sloan...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.